Skip to content

Free cash flow margin at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
15.7%-2.1pp
Danaher logo
DanaherDHR
21.4%+0.8pp
Repligen logo
RepligenRGEN
21.2%+6.1pp
ADMA Biologics logo
ADMA BiologicsADMA
21.2%+1.4pp
Revvity logo
RevvityRVTY
17%-1.9pp
TEC
Bio-TechneTECH
22.3%+4.0pp

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+186%
Enterprise value$954.59M+182%
P/S4.2×+2.9×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s free cash flow margin?
Maravai LifeSciences Holdings, Inc. (MRVI) reported free cash flow margin of -25.7% in Q1 2026.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s free cash flow margin?
Over 3 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s free cash flow margin has grown at a -5.2% compound annual growth rate (CAGR), from 44.6% to -38.1%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.